Manila, Philippines

Lourdes J Cruz

This inventor holds 22 USPTO granted patents, primarily in Conotoxin Peptides. Top assignees: University of Utah Research Foundation, The Salk Institute, Cognetix, Inc.. Active years: 1984-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lourdes J Cruz. Retrieved from https://idiyas.com/inventor/lourdes-j-cruz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 95.5

Average Co-Inventor Count = 6.6

ph-index = 7

Forward Citations = 176(Granted Patents)


Location History:

  • Sta Mesa, Manila, PH (1984)
  • Manila, PH (2002 - 2004)
  • Salt Lake City, UT (US) (1995 - 2006)
  • Sta. Mesa, PH (2008)

Company Filing History:


Years Active: 1984-2008

Loading Chart...
Areas of Expertise:
Conotoxin Peptides
Mu-Conopeptides
Gamma-Conopeptides
Conantokins
Contulakin-G
Contryphan Peptides
Bromo-Tryptophan
A-Lineage
Nucleic Acids
Analogues
Peptide Structures
Bioactive Compounds
22 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Lourdes J. Cruz in the Field of Conotoxin Peptides

Introduction

Lourdes J. Cruz, based in Manila, Philippines, is a renowned inventor with an impressive portfolio of 22 patents. Her pioneering work in the field of conotoxin peptides has significantly advanced our understanding of pain management and neuromuscular functions. Her inventions are highly regarded for their potential therapeutic applications, particularly in analgesia.

Latest Patents

Cruz's latest patents include innovative inventions related to conotoxin peptides. One of her notable patents describes relatively short conotoxin peptides, consisting of 10-20 residues. These peptides, which can be derived from the venom of cone snails, exhibit analgesic activity and are beneficial for treating or preventing pain. Another significant invention involves substantially pure conotoxins that inhibit synaptic transmissions at neuromuscular junctions. These conotoxins specifically target receptors such as the acetyl-choline receptor and ion channels, making them valuable not only in vivo but also in laboratory assays. The peptides’ length has allowed for their synthesis through chemical methods or recombinant DNA techniques, and these peptides may be used to incorporate plant defense genes into various plant species.

Career Highlights

Throughout her career, Lourdes J. Cruz has collaborated with prominent research institutions, including the University of Utah Research Foundation. Her contributions to the field have not only enhanced scientific understanding but have also opened new avenues for medical research and drug development.

Collaborations

Cruz has worked alongside esteemed colleagues such as Baldomero M. Olivera and David R. Hillyard. These collaborations have helped drive innovations in the research of conotoxins and their applications, fostering an environment of scientific growth and discovery.

Conclusion

Lourdes J. Cruz continues to be a leading figure in the field of innovations surrounding conotoxin peptides. Her 22 patents not only showcase her creativity and expertise but also underscore her commitment to advancing the medical field. Through her groundbreaking work, Cruz has made significant strides in pain management solutions and neuromuscular research, making her an inspirational inventor in contemporary science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…